Anthrax as a biological weapon, 2002: updated recommendations for management.

By T. Inglesby, T. O'Toole, D. Henderson, J. Bartlett, M. Ascher, E. Eitzen, A. Friedlander, J. Gerberding, J. Hauer, J. Hughes and 6 more. Journal of the American Medical Association (JAMA), 2002

990 citations recorded by the source corpus.

Subfields: Emergency Medical Services, Infectious Diseases, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/aa29a6fee4f56955f12b85c01b734a22f5ebfe12

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. L. Petersen
2. L. Chiarello
3. J. Siegel
4. M. Jackson
5. J. Bartlett
6. E. Rhinehart
7. F. Tenover

In Molecular Biology

1. L. Chiarello
2. J. Siegel
3. M. Jackson
4. E. Rhinehart
5. F. Tenover

Citations in the corpus

• Investigation of Bioterrorism-Related Anthrax, United States, 2001: Epidemiologic Findings (2002, background): “Before the bioterrorismrelated anthrax cases in 2001, clinician recognition of clinical findings suggestive of cutaneous or inhalational anthrax is presumed to have been very low (43,44).”
• Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults (2003, background): “The mortality rates in this and prior inhalation anthrax cases in the antibiotic era were 45%–80% [95].”
• 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings (2007, background): “other substance DE Until decontamination of environment complete.(203) Wear respirator (N95 mask or PAPR),”